Public Profile

EMS

EMS, officially known as EMS S/A, is a leading Brazilian pharmaceutical company headquartered in Jaguariúna, São Paulo. Founded in 1964, EMS has established itself as a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and branded medications. With a strong presence across Brazil and significant operations in Latin America, EMS has achieved notable milestones, including becoming one of the largest pharmaceutical companies in Brazil. The company is renowned for its extensive portfolio of high-quality products, which includes prescription medications, over-the-counter drugs, and a variety of therapeutic classes. EMS distinguishes itself through its commitment to innovation and quality, ensuring that its offerings meet the highest industry standards. With a robust market position, EMS continues to contribute significantly to the healthcare sector, making it a trusted name among healthcare professionals and patients alike.

DitchCarbon Score

How does EMS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

44

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

EMS's score of 44 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

60%

Let us know if this data was useful to you

EMS's reported carbon emissions

In 2023, EMS reported total carbon emissions of approximately 69,950 kg CO2e, comprising 32,870 kg CO2e from Scope 1, 37,090 kg CO2e from Scope 2, and a minimal 16 kg CO2e from Scope 3 emissions. This marks a significant reduction from previous years, particularly from 2022, when total emissions were about 74,542,000 kg CO2e, with Scope 1 emissions at 72,542,000 kg CO2e and Scope 2 emissions at approximately 17,261,000 kg CO2e. The company has demonstrated a commitment to reducing its carbon footprint, although specific reduction targets or initiatives have not been disclosed. EMS's emissions data reflects a proactive approach to climate responsibility, aligning with industry standards for transparency and accountability in emissions reporting. The headquarters of EMS is located in Brazil (BR), and the organisation continues to monitor and report its emissions across all relevant scopes.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2020202120222023
Scope 1
72,025,000
00,000,000
00,000,000
00,000
Scope 2
11,850,000
00,000,000
0,000,000
00,000
Scope 3
-
-
000,000
00

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. EMS's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for EMS is in BR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

EMS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hypera Pharma

BR
Pharmaceutical Preparation Manufacturing
Updated 3 minutes ago

Pint Pharma GmbH

AT
Pharmaceutical Preparation Manufacturing
Updated 3 minutes ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 3 minutes ago

Abbott

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 minutes ago

Aventis Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 minutes ago

Laboratorios Bago De Bolivia S.A.

BO
Pharmaceutical Preparation Manufacturing
Updated 3 minutes ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers